Management ChangeJul 20, 2026, 06:11 AM
Immix Biopharma Announces Richard Graydon's Termination
AI Summary
Immix Biopharma, Inc. announced the termination of Richard Graydon, effective July 17, 2026. The company stated that the termination was for reasons unrelated to his activities at the company. Management believes that due to his short tenure, there will be no material effect on the business.
Key Highlights
- Richard Graydon was terminated from Immix Biopharma as of July 17, 2026.
- The termination was for reasons unrelated to his activities at the company.
- Management believes there is no material effect on the business due to his short tenure.
Price Impact
More from IMMX